Cyclophosphamide in scleroderma lung disease.
Andreu
José-Luis
JL
Silva
Lucía
L
D003520:Cyclophosphamide / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D017563:Lung Diseases, Interstitial / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D012867:Skin / Q000187:drug effects; D014797:Vital Capacity / Q000187:drug effects*
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide